Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis. An Official American Thoracic Society Research Statement-Reference-Cited by-同舟云学术

Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis. An Official American Thoracic Society Research Statement

Published:2019-09-15 Issue:6 Volume:200 Page:e31-e43
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Sears Catherine R.,Peikert Tobias,Possick Jennifer D.,Naidoo Jarushka,Nishino Mizuki,Patel Sandip P.,Camus Philippe,Gaga Mina^ORCID,Garon Edward B.,Gould Michael K.,Limper Andrew H.,Montgrain Philippe R.,Travis William D.,Rivera M. Patricia

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.201906-1202ST

Reference69 articles.

1. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

2. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

4. Monitoring immune-checkpoint blockade: response evaluation and biomarker development

5. Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome of immune checkpoint inhibitor treatment in non-small cell lung cancer patients with interstitial lung abnormalities: clinical utility of subcategorizing interstitial lung abnormalities;Cancer Immunology, Immunotherapy;2024-09-05

2. Immune checkpoint inhibitor therapy‑related pneumonitis: How, when and why to diagnose and manage (Review);Experimental and Therapeutic Medicine;2024-07-30

3. Immune checkpoint inhibitor increased mortality in lung cancer patients with Pneumocystis jirovecii pneumonia: a comparative retrospective cohort study;Frontiers in Oncology;2024-07-05

4. Lethal Immune-Related Pneumonitis after Durvalumab Therapy for Small Cell Lung Cancer: A First Case in China;Case Reports in Oncology;2024-06-19

5. Are Immune Checkpoint Inhibitors Safe and Effective in Lung Cancer Patients with Pre-Existing Interstitial Lung Disease?;Immunotherapy;2024-03-21